We have shown that Ac53FaxNeu5Ac treatment on human pancreatic cancer cells decreased their sialic acid, reduced their E-selectin adhesion—the prior step to tumour extravasation—and their migration and invasion capabilities. This evidence concerns the gene SELE and pancreatic neoplasm.